The largest database of trusted experimental protocols

2 protocols using cd90 1 clone ox 7

1

Immunophenotypic Analysis of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the immunophenotypic analysis, third passage MSCc and MSCd were dissociated
and suspended in blocking solution containing cold PBS supplemented with 0.5%
bovine serum albumin (BSA). The cells were treated with rat Fc block (CD32,
Cat#550271; BD Biosciences, San Jose, CA, USA) for 20 minutes before incubation
with antibodies. The following antibodies conjugated with fluorescein
isothiocyanate (FITC), phycoerythrin (PE), or biotin were used: CD29 (clone
Ha2/5, Cat#555005, dilution 1:50; BD Biosciences), CD90-1 (clone OX-7,
Cat#551401, dilution 1:25; BD Biosciences), CD45 (clone 30-F11, Cat#553077,
dilution 1:50; BD Biosciences), and CD34 (clone RAM34, Cat#551387, dilution
1:50; BD Biosciences). The corresponding isotypes (BD Biosciences) were used as
nonspecific binding controls. After incubation at 4ºC for 20 minutes, the cells
were washed with PBS/0.5% BSA, centrifuged at 300 xg for 5 minutes, and
suspended in PBS for data acquisition. DAPI 0.1 µg/mL (Cat# D9452,
Sigma-Aldrich) was added to exclude dead cells. The samples were acquired in a
BD FACSAria II flow cytometer (BD Biosciences) and the resulting data were
analyzed using the software FlowJo, version 10.1.
+ Open protocol
+ Expand
2

Tumor Immune Cell Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor tissue was mechanically dissociated and digested in 0.7 mg/mL Collagenase D (Roche) and 3 mg/mL DNase I (Roche) for 30–45 min to obtain single-cell suspension. For experiments looking at tumor-infiltrating leukocytes (TIL), TIL were isolated using Percoll gradient prior to staining. For experiments looking at B16RFP+ tumor cells, cells were stained immediately after digestion for 20 min. Cells were blocked with anti-CD16/32 (clone 93; Biolegend) prior to surface staining. Antibodies against the following antigens were used: CD11a (clone M17/4; ThermoFisher), CD8a (clone 53-6.7; BD Biosciences or Biolegend or eBioscience), CD45 (clone 30-F11; Invitrogen or eBioscience), CD45.1 (clone A20; Biolegend), CD3 (clone eBio500A2; eBioscience), CD45.2 (clone 104; eBioscience), CD90.1 (clone OX-7; BD Biosciences), CD127 (clone A7R34; eBioscience or clone SB/199; Biolegend), KLRG1 (clone 2F1/KLRG1; Biolegend or eBioscience), PD-1 (clone RMP1-30; eBioscience), NKG2A/C/E (clone 20d5; eBioscience), LAG3 (clone C9B7W; Biolegend), CD44 (clone IM7; eBioscience or Biolegend or BD Biosciences), Ly6C (clone HK1.4; Biolegend), Ly6G (clone 1A8; Biolegend), CD11b (M1/70; eBioscience or Biolegend), Qa-1b (clone 6A8.6F10.1A6; Miltenyi Biotec), and PD-L1 (10F.9G2; Biolegend).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!